NCT00987012

Brief Summary

It has been shown in laboratory studies that pomegranate juice contains anti-viral action against influenza. The researchers wish to investigate the effect of pomegranate juice on patients suffering from influenza A (seasonal or swine flu).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 30, 2009

Completed
1 day until next milestone

Study Start

First participant enrolled

October 1, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Last Updated

September 30, 2009

Status Verified

September 1, 2009

Enrollment Period

6 months

First QC Date

September 29, 2009

Last Update Submit

September 29, 2009

Conditions

Influenza ASwine Flu

Outcome Measures

Primary Outcomes (1)

  • Early relief of influenza symptoms

    Within one week

Study Arms (2)

Pomegranate juice

EXPERIMENTAL
Dietary Supplement: Pomegranate juice

Placebo drink

PLACEBO COMPARATOR
Dietary Supplement: Placebo drink

Interventions

Pomegranate juiceDIETARY_SUPPLEMENT

Twice daily ingestion of pomegranate juice over 4-5 days

Pomegranate juice
Placebo drinkDIETARY_SUPPLEMENT

Twice daily ingestion of placebo drink over 4-5 days

Placebo drink

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals confirmed and suffering from Influenza A

You may not qualify if:

  • Individuals suffering from influenza included in the high risk group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillel Yaffe Medical Center

Hadera, 38100, Israel

Location

MeSH Terms

Conditions

Orthomyxoviridae Infections

Condition Hierarchy (Ancestors)

RNA Virus InfectionsVirus DiseasesInfections

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 29, 2009

First Posted

September 30, 2009

Study Start

October 1, 2009

Primary Completion

April 1, 2010

Last Updated

September 30, 2009

Record last verified: 2009-09

Locations

IL(1)